HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide.

CP: Immunology HIV vaccine antibody-antigen binding cryo-EM structure envelope trimer fusion peptide glycan hole immunogen design reproducible antibody class site of vulnerability

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
25 07 2023
Historique:
received: 26 02 2023
revised: 18 04 2023
accepted: 21 06 2023
medline: 31 7 2023
pubmed: 12 7 2023
entrez: 12 7 2023
Statut: ppublish

Résumé

Elicitation of antibodies that neutralize the tier-2 neutralization-resistant isolates that typify HIV-1 transmission has been a long-sought goal. Success with prefusion-stabilized envelope trimers eliciting autologous neutralizing antibodies has been reported in multiple vaccine-test species, though not in humans. To investigate elicitation of HIV-1 neutralizing antibodies in humans, here, we analyze B cells from a phase I clinical trial of the "DS-SOSIP"-stabilized envelope trimer from strain BG505, identifying two antibodies, N751-2C06.01 and N751-2C09.01 (named for donor-lineage.clone), that neutralize the autologous tier-2 strain, BG505. Though derived from distinct lineages, these antibodies form a reproducible antibody class that targets the HIV-1 fusion peptide. Both antibodies are highly strain specific, which we attribute to their partial recognition of a BG505-specific glycan hole and to their binding requirements for a few BG505-specific residues. Prefusion-stabilized envelope trimers can thus elicit autologous tier-2 neutralizing antibodies in humans, with initially identified neutralizing antibodies recognizing the fusion-peptide site of vulnerability.

Identifiants

pubmed: 37436899
pii: S2211-1247(23)00766-0
doi: 10.1016/j.celrep.2023.112755
pmc: PMC10491024
mid: NIHMS1920497
pii:
doi:

Substances chimiques

AIDS Vaccines 0
Antibodies, Neutralizing 0
env Gene Products, Human Immunodeficiency Virus 0
HIV Antibodies 0
Peptides 0

Types de publication

Clinical Trial, Phase I Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112755

Subventions

Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA AI005022
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Cell Host Microbe. 2019 Jun 12;25(6):873-883.e5
pubmed: 31194940
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17624-9
pubmed: 25422458
PLoS Pathog. 2013 Sep;9(9):e1003618
pubmed: 24068931
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W34-40
pubmed: 23671333
Immunity. 2013 Aug 22;39(2):245-58
pubmed: 23911655
Nat Commun. 2017 Nov 21;8(1):1655
pubmed: 29162799
Protein Sci. 2018 Jan;27(1):293-315
pubmed: 29067766
Nature. 2022 Sep;609(7929):998-1004
pubmed: 36131022
Nature. 1985 Jul 4-10;316(6023):72-4
pubmed: 2989707
Bioinformatics. 2019 Sep 1;35(17):2974-2981
pubmed: 30657870
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):E4088-97
pubmed: 24106303
Nature. 1985 Jul 4-10;316(6023):69-72
pubmed: 2989706
Nat Struct Mol Biol. 2015 Nov;22(11):833-4
pubmed: 26581513
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Nature. 2014 Nov 6;515(7525):138-42
pubmed: 25186731
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Immunity. 2014 May 15;40(5):669-80
pubmed: 24768348
Nat Med. 2021 Dec;27(12):2234-2245
pubmed: 34887575
Immunity. 2019 Nov 19;51(5):915-929.e7
pubmed: 31732167
EClinicalMedicine. 2022 Jun 01;48:101477
pubmed: 35783486
Nature. 2012 Nov 15;491(7424):406-12
pubmed: 23151583
J Virol. 2020 Jun 16;94(13):
pubmed: 32295908
Science. 2011 Sep 16;333(6049):1593-602
pubmed: 21835983
Cell. 1986 Jun 6;45(5):637-48
pubmed: 2423250
Nat Methods. 2015 Oct;12(10):943-6
pubmed: 26280328
Vaccine. 2021 Jun 8;39(25):3379-3387
pubmed: 34020817
PLoS Pathog. 2020 Aug 31;16(8):e1008753
pubmed: 32866207
Bioinformatics. 2017 Oct 01;33(19):3051-3057
pubmed: 28582506
J Virol. 2010 Feb;84(3):1439-52
pubmed: 19939925
Nature. 2019 Feb;566(7744):398-402
pubmed: 30760926
Science. 2009 Oct 9;326(5950):285-9
pubmed: 19729618
J Virol. 2017 Jul 27;91(16):
pubmed: 28592540
Cell Rep. 2021 Nov 2;37(5):109922
pubmed: 34731616
Glycobiology. 2019 Apr 1;29(4):320-331
pubmed: 30689864
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
J Virol. 2015 Oct 14;90(1):76-91
pubmed: 26468542
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
PLoS One. 2019 Apr 17;14(4):e0215163
pubmed: 30995238
Cell Rep. 2020 Nov 24;33(8):108432
pubmed: 33238130
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
Science. 2016 May 13;352(6287):828-33
pubmed: 27174988
Science. 2011 Sep 16;333(6049):1633-7
pubmed: 21764753
Nat Struct Mol Biol. 2015 Jul;22(7):522-31
pubmed: 26098315
Sci Transl Med. 2022 Sep 7;14(661):eabo5598
pubmed: 36070369
Nat Commun. 2022 Dec 14;13(1):7733
pubmed: 36517467
J Struct Biol. 2005 Oct;152(1):36-51
pubmed: 16182563
J Comput Chem. 2011 Nov 15;32(14):3135-41
pubmed: 21815173
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Structure. 2019 Jan 2;27(1):196-206.e6
pubmed: 30471922
AIDS. 2014 Jan 14;28(2):163-9
pubmed: 24361678
Nat Commun. 2021 Nov 9;12(1):6470
pubmed: 34753907
Clin Chim Acta. 1994 Jan 31;224(2):191-7
pubmed: 8004789
Nature. 2003 Mar 20;422(6929):307-12
pubmed: 12646921
Protein Sci. 2020 Apr;29(4):1069-1078
pubmed: 31730249
Cell Rep. 2020 Oct 27;33(4):108322
pubmed: 33091382
BMC Bioinformatics. 2004 Jun 04;5:69
pubmed: 15180909
J Struct Biol. 2005 Jul;151(1):41-60
pubmed: 15890530
Science. 2015 Jul 10;349(6244):156-61
pubmed: 26089355
PLoS Pathog. 2016 Sep 14;12(9):e1005864
pubmed: 27627672
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
Cell Rep. 2016 Aug 30;16(9):2327-38
pubmed: 27545891
Cell Rep. 2016 May 31;15(9):1986-99
pubmed: 27210756
Cell. 2015 Dec 17;163(7):1702-15
pubmed: 26687358
Cell Rep. 2017 Apr 25;19(4):719-732
pubmed: 28445724
Cell Rep. 2018 Feb 13;22(7):1798-1809
pubmed: 29444432
Nat Med. 2018 Jun;24(6):857-867
pubmed: 29867235
Cell. 2019 Jul 25;178(3):567-584.e19
pubmed: 31348886
Nature. 2011 Sep 22;477(7365):466-70
pubmed: 21849977
PLoS Pathog. 2015 May 29;11(5):e1004932
pubmed: 26023780
Semin Immunol. 2020 Aug;50:101428
pubmed: 33246736
J Synchrotron Radiat. 2004 Jan 1;11(Pt 1):53-5
pubmed: 14646133
Science. 2010 Aug 13;329(5993):856-61
pubmed: 20616233
MAbs. 2009 Sep-Oct;1(5):439-42
pubmed: 20065632

Auteurs

Shuishu Wang (S)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Flavio Matassoli (F)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Baoshan Zhang (B)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Tracy Liu (T)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Chen-Hsiang Shen (CH)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Tatsiana Bylund (T)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Timothy Johnston (T)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Amy R Henry (AR)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

I-Ting Teng (IT)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Prabhanshu Tripathi (P)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Jordan E Becker (JE)

Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10027, USA; Department of Biochemistry and Molecular Biophysics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA.

Anita Changela (A)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Ridhi Chaudhary (R)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Cheng Cheng (C)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Martin Gaudinski (M)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Jason Gorman (J)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Darcy R Harris (DR)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Myungjin Lee (M)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Nicholas C Morano (NC)

Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10027, USA; Department of Biochemistry and Molecular Biophysics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA.

Laura Novik (L)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Sijy O'Dell (S)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Adam S Olia (AS)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Danealle K Parchment (DK)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Reda Rawi (R)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Jesmine Roberts-Torres (J)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Tyler Stephens (T)

Electron Microscopy Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.

Yaroslav Tsybovsky (Y)

Electron Microscopy Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.

Danyi Wang (D)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

David J Van Wazer (DJ)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Tongqing Zhou (T)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Nicole A Doria-Rose (NA)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Richard A Koup (RA)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Lawrence Shapiro (L)

Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10027, USA; Department of Biochemistry and Molecular Biophysics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA.

Daniel C Douek (DC)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Adrian B McDermott (AB)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Peter D Kwong (PD)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA; Department of Biochemistry and Molecular Biophysics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA. Electronic address: pdkwong@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH